Although patients with EML4-ALK share several clinicopathological features with patients with EGFR mutations, such as never/light smoking history and adenocarcinoma histology, the current meta-analysis found that EML4-ALK fusion gene was mutually exclusive for EGFR mutations, thus suggesting a distinct genetic subtype of lung adenocarcinoma. Here, EML4 is linked to lung adenocarcinoma.